
A subject receives a shot in the first-stage safety research study medical trial of Moderna’s potential vaccine in Seattle in March. Image: AP
- No severe adverse effects among volunteers evaluated, but majority reported moderate or moderate responses such as tiredness, headache, chills or muscle pains
- US company was first to start human testing of vaccine candidate on March16 It will begin stage 3 trials with 30,000 volunteers on July 27
Topic |.
Coronavirus pandemic
Comments
Post a Comment